Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 19 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
| APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-03-10 | 2017-04-10 | 324 |
| APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-10 | 658 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-07 | 113 |
| APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2017-03-11 | 2017-04-07 | 426 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 83 |
| APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 80 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 712 |
| APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 709 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 55 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 33 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 86 |
| APO-MEMANTINE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 381 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-12 | 2017-04-04 | 674 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-10 | 2017-04-04 | 408 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-04 | 592 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 67 |
| APO-OXYBUTYNIN | 5 MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 414 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-01 | 384 |
| APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-01 | 387 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
| APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
| APO-OXAZEPAM | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 |